Diligence memo · auto-generated · as of July 2, 2026

Liquet Medical Inc.

Liquet Medical Inc. looks under-valued against its niche peers and is quiet on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Liquet Medical Inc. operates in Biotechnology, based in GLEN ALLEN.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Liquet Medical Inc. has raised $3.2M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.1M on 2024-12-23.

Most recent recorded round closed around 2024-12-23.

Valuation (modeled)modeled

Provath models Liquet Medical Inc. at approximately $3.9M (range $762K–$9.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.28× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 10 months.

Last raise 18 mo ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

The last round stepped up 1.7× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 35% of Biotechnology peers (4293 compared).

Modeled value ranks above 8% of those peers.

Closest niche peers: Mesentech Inc., Marlinspike Therapeutics, Inc., Microbial Machines, Inc., Pearl Diagnostics, Inc., Crossfire Medical Inc.

Peoplefiled

12 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.